Barclays’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-33,172
| Closed | -$10K | – | 7480 |
|
|
2019
Q2 | $10K | Sell |
33,172
-12,499
| -27% | -$33.7K | ﹤0.01% | 6563 |
|
|
2019
Q1 | $211K | Buy |
45,671
+45,259
| +10,985% | +$214K | ﹤0.01% | 4789 |
|
|
2018
Q4 | $1K | Sell |
412
-66,489
| -99% | -$462K | ﹤0.01% | 6876 |
|
|
2018
Q3 | $675K | Sell |
66,901
-40,380
| -38% | -$322K | ﹤0.01% | 4012 |
|
|
2018
Q2 | $776K | Buy |
107,281
+46,394
| +76% | +$323K | ﹤0.01% | 3537 |
|
|
2018
Q1 | $369K | Buy |
60,887
+2,123
| +4% | +$17.5K | ﹤0.01% | 4263 |
|
|
2017
Q4 | $566K | Buy |
58,764
+53,679
| +1,056% | +$351K | ﹤0.01% | 3681 |
|
|
2017
Q3 | $45K | Buy |
5,085
+2,953
| +139% | +$30.5K | ﹤0.01% | 5407 |
|
|
2017
Q2 | $27K | Sell |
2,132
-18,895
| -90% | -$224K | ﹤0.01% | 5660 |
|
|
2017
Q1 | $220K | Buy |
21,027
+6,784
| +48% | +$72.3K | ﹤0.01% | 4217 |
|
|
2016
Q4 | $132K | Buy |
14,243
+11,534
| +426% | +$130K | ﹤0.01% | 4557 |
|
|
2016
Q3 | $32K | Buy |
+2,709
| New | +$41.2K | ﹤0.01% | 5244 |
|
|
2016
Q2 | – | Sell |
-5,377
| Closed | -$81K | – | 6802 |
|
|
2016
Q1 | $81K | Buy |
5,377
+4,329
| +413% | +$82.2K | ﹤0.01% | 4503 |
|
|
2015
Q4 | $28K | Sell |
1,048
-184,305
| -99% | -$5.11M | ﹤0.01% | 5087 |
|
|
2015
Q3 | $5.19M | Buy |
185,353
+92,963
| +101% | +$3.42M | 0.01% | 1349 |
|
|
2015
Q2 | $3.23M | Buy |
92,390
+90,894
| +6,076% | +$2.83M | ﹤0.01% | 1844 |
|
|
2015
Q1 | $43K | Sell |
1,496
-1,926
| -56% | -$50.9K | ﹤0.01% | 5388 |
|
|
2014
Q4 | $72K | Sell |
3,422
-4,628
| -57% | -$91.5K | ﹤0.01% | 5443 |
|
|
2014
Q3 | $153K | Sell |
8,050
-8,078
| -50% | -$127K | ﹤0.01% | 4972 |
|
|
2014
Q2 | $250K | Buy |
16,128
+4,478
| +38% | +$72.4K | ﹤0.01% | 4616 |
|
|
2014
Q1 | $239K | Buy |
11,650
+5,488
| +89% | +$109K | ﹤0.01% | 4617 |
|
|
2013
Q4 | $77K | Buy |
6,162
+5,598
| +993% | +$77.6K | ﹤0.01% | 5864 |
|
|
2013
Q3 | $6K | Sell |
564
-231
| -29% | -$1.9K | ﹤0.01% | 6946 |
|
|
2013
Q2 | $4K | Buy |
+795
| New | +$2.91K | ﹤0.01% | 7427 |
|
Barclays's INSY Position: Q3 2019 in Review
Barclays sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 33,172 shares — an estimated $10K sold.
Barclays first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $5.19M in Q3 2015. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.
- Barclays reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Barclays sold 33,172 Insys Therapeutics, Inc. shares in Q3 2019, an estimated $10K.
- Barclays first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Barclays's Insys Therapeutics, Inc. position peaked at $5.19M in Q3 2015.
- 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.